These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from July 31 through Aug. 6, 2025. Source: VerityData

Original Filings

Ermenegildo Zegna $(ZGN)$ Temasek Holdings disclosed a new position in the luxury apparel company of 26,821,043 shares. Temasek Holdings purchased 7,041,851 of those shares from June 2 through June 27, at per share prices ranging from $8.41 to $9.05. Following those purchases, Temasek Holdings owns 10% of Ermenegildo Zegna's outstanding stock. Shares of Ermenegildo Zegna have lost roughly 2.5% of their value since the start of this year.

Increases in Holdings

Paramount Global (PARA) Gamco Investors raised its stake in the media firm to 4,894,726 shares. Gamco purchased 72,695 Paramount Global shares from June 2 through July 29, at per share prices ranging from $22.39 to $23.20, but offset those purchases through the sale of 42,254 Paramount Global shares from June 3 to July 29 at $22.36 to $23.30 apiece.

Following the latest activity, Gamco owns 12.03% of Paramount Global's outstanding stock. Shares of Paramount Global have gained 4.3% in value since the start of this year.

Rocket Cos. $(RKT)$ ValueAct Capital increased its stake in the mortgage lender and financial-services firm to 25,395,627 shares, or 9.9% of shares outstanding. The value-oriented hedge fund purchased 2,690,672 Rocket shares from July 14 through July 31, at per share prices ranging from $13.31 to $15.16.

Those purchases followed its July 2 acquisition of 4,601,518 shares as part of Rocket's stock-for-stock acquisition of Redfin. ValueAct has invested $324,555,683, or $12.78 per share, to acquire its holding in Rocket Cos., inclusive of its earlier investment in Redfin.

In a May 13D filing, ValueAct disclosed that it had spoken with Rocket's management and board members about a wide range of issues, including possible board representation.

Decreases in Holdings

RingCentral$(RNG)$ Sylebra Capital lowered its stake in the cloud communications firm to 3,912,007 shares. Sylebra Capital did so through the sale of 3,624,216 RingCentral shares from June 27 through July 25, at per share prices ranging from $26.10 to $29.70.

Following the latest sales, Sylebra Capital continues to own 4.9% of RingCentral's outstanding stock, placing Sylebra below the 5% threshold that would require it to report further purchases or sales. Shares of RingCentral have lost approximately 13.9% of their value since the start of this year.

ARS Pharmaceuticals$(SPRY)$ Deerfield Capital reduced its stake in the pharmaceutical company to 7,610,217 shares. Deerfield Capital did so through the sale of 1,023,320 ARS Pharmaceuticals shares from July 23 through July 30, at per share prices ranging from $18 to $18.58. Following the latest sales, Deerfield Capital continues to own 7.8% of ARS Pharmaceuticals' outstanding stock. Shares of ARS Pharmaceuticals have gained approximately 67.9% in value in 2025.

Email: editors@barrons.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

August 08, 2025 13:56 ET (17:56 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.